| Dr Jeffrey Borden Mccallum, MD | |
|
302 Medical Park Ct, Morehead City, NC 28557-4346 | |
| (252) 247-2013 | |
| (252) 247-7299 |
| Full Name | Dr Jeffrey Borden Mccallum |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 22 Years |
| Location | 302 Medical Park Ct, Morehead City, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518997188 | NPI | - | NPPES |
| 752086094A | Medicaid | GA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 054871 (Georgia) | Secondary |
| 207R00000X | Internal Medicine | 2005-01961 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Carteret Health Care Home Health And Hospice | Morehead city, NC | Home health agency |
| Kindred At Home | Morehead city, NC | Home health agency |
| Carteret General Hospital | Morehead city, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Carteret Medical Group Llc | 5698947794 | 16 |
News Archive
In an unexpected discovery, Georgetown University Medical Center researchers have identified what appears to be a significant vascular defect in patients with moderately severe Parkinson's disease.
Regeneron Pharmaceuticals, Inc. and Sanofi today announced that the European Medicine Agency's Committee for Medicinal Products for Human Use has adopted a positive opinion for the marketing authorization of Praluent (alirocumab), recommending its approval for use in certain adult patients with hypercholesterolemia.
Merck Serono, a division of Merck KGaA, Darmstadt, Germany announced today that long-term follow-up data of a randomized Phase II study of two cilengitide doses in recurrent glioblastoma were presented at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.
If you are a parent who has conceived using Ferring Pharmaceuticals' fertility products, you can win a $10,000 education fund to support your child's future. Two other education fund prizes will also be awarded.
› Verified 4 days ago
| Entity Name | Carteret Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700164464 PECOS PAC ID: 5698947794 Enrollment ID: O20111014000289 |
News Archive
In an unexpected discovery, Georgetown University Medical Center researchers have identified what appears to be a significant vascular defect in patients with moderately severe Parkinson's disease.
Regeneron Pharmaceuticals, Inc. and Sanofi today announced that the European Medicine Agency's Committee for Medicinal Products for Human Use has adopted a positive opinion for the marketing authorization of Praluent (alirocumab), recommending its approval for use in certain adult patients with hypercholesterolemia.
Merck Serono, a division of Merck KGaA, Darmstadt, Germany announced today that long-term follow-up data of a randomized Phase II study of two cilengitide doses in recurrent glioblastoma were presented at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.
If you are a parent who has conceived using Ferring Pharmaceuticals' fertility products, you can win a $10,000 education fund to support your child's future. Two other education fund prizes will also be awarded.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jeffrey Borden Mccallum, MD 302 Medical Park Ct, Morehead City, NC 28557-4346 Ph: (252) 247-2013 | Dr Jeffrey Borden Mccallum, MD 302 Medical Park Ct, Morehead City, NC 28557-4346 Ph: (252) 247-2013 |
News Archive
In an unexpected discovery, Georgetown University Medical Center researchers have identified what appears to be a significant vascular defect in patients with moderately severe Parkinson's disease.
Regeneron Pharmaceuticals, Inc. and Sanofi today announced that the European Medicine Agency's Committee for Medicinal Products for Human Use has adopted a positive opinion for the marketing authorization of Praluent (alirocumab), recommending its approval for use in certain adult patients with hypercholesterolemia.
Merck Serono, a division of Merck KGaA, Darmstadt, Germany announced today that long-term follow-up data of a randomized Phase II study of two cilengitide doses in recurrent glioblastoma were presented at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.
If you are a parent who has conceived using Ferring Pharmaceuticals' fertility products, you can win a $10,000 education fund to support your child's future. Two other education fund prizes will also be awarded.
› Verified 4 days ago
Dr. Sajeev P Vettichira, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 147 Hwy 24, Hestron Plaza, Suite 102, Morehead City, NC 28557 Phone: 252-726-4000 Fax: 252-726-2530 | |
Alonzo James Davis Iv, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 221a Professional Cir, Morehead City, NC 28557 Phone: 252-726-5767 Fax: 252-726-7573 | |
Dr. Terrence Lynn Goodman, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 306 Medical Park Ct, Morehead City, NC 28557 Phone: 252-247-2013 Fax: 252-247-7299 | |
Dr. William Thomas Walker Jr., MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 306 Medical Park Ct, Morehead City, NC 28557 Phone: 252-247-2013 Fax: 252-247-7299 | |
Dr. Timothy Alan Busteed, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4725 Country Club Rd, Morehead City, NC 28557 Phone: 252-727-5200 Fax: 252-727-5205 | |
Dr. Mary Katherine Lawrence, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 302 Medical Park Ct, Morehead City, NC 28557 Phone: 252-247-2013 Fax: 252-247-7299 | |
Vicki M Morris, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3500 Arendell St, Morehead City, NC 28557 Phone: 252-247-2013 Fax: 252-247-7299 |